Results     03-May-13
Announcements
Astrazeneca Pharma India reports net loss of Rs 18.58 crore in the March 2013 quarter
Sales rise 3.45% to Rs 94.85 crore
Net Loss of Astrazeneca Pharma India reported to Rs 18.58 crore in the quarter ended March 2013 as against net loss of Rs 33.01 crore during the previous quarter ended March 2012. Sales rose 3.45% to Rs 94.85 crore in the quarter ended March 2013 as against Rs 91.69 crore during the previous quarter ended March 2012.

For the Audited full year,net loss reported to Rs 89.53 crore in the year ended March 2013 as against net profit of Rs 19.77 crore during the previous year ended March 2012. Sales declined 26.55% to Rs 390.25 crore in the year ended March 2013 as against Rs 531.28 crore during the previous year ended March 2012.

ParticularsQuarter EndedYear Ended
 Mar. 2013Mar. 2012% Var.Mar. 2013Mar. 2012% Var.
Sales94.8591.69 3 390.25531.28 -27
OPM %-14.52-53.62 73 -17.545.70 -408
PBDT-13.10-47.15 72 -57.9936.60 PL
PBT-18.58-48.96 62 -70.2729.26 PL
NP-18.58-33.01 44 -89.5319.77 PL

Previous News
  Astrazeneca Pharma India standalone net profit rises 96.78% in the June 2022 quarter
 ( Results - Announcements 08-Aug-22   14:55 )
  Board of Astrazeneca Pharma India recommends final dividend
 ( Corporate News - 28-May-24   09:52 )
  Astrazeneca Pharma India fixes record date for final dividend
 ( Market Beat - Reports 27-Jun-22   17:01 )
  Astrazeneca Pharma India standalone net profit rises 128.60% in the March 2024 quarter
 ( Results - Announcements 28-May-24   07:37 )
  AstraZeneca Pharma hits 52 week high after Q1 PAT soars to Rs 54 cr
 ( Hot Pursuit - 14-Aug-23   16:04 )
  Board of Astrazeneca Pharma India recommends Final Dividend
 ( Corporate News - 28-May-22   10:09 )
  Astrazeneca Pharma India standalone net profit rises 236.78% in the June 2019 quarter
 ( Results - Announcements 07-Aug-19   16:27 )
  Astrazeneca Pharma India schedules board meeting
 ( Corporate News - 25-May-23   15:01 )
  Astrazeneca Pharma gains after CDSCO nod to sale Tremelimumab solution
 ( Hot Pursuit - 02-Jun-23   10:05 )
  Volumes spurt at Astrazeneca Pharma India Ltd counter
 ( Hot Pursuit - 08-Sep-20   14:31 )
  Astrazeneca Pharma India set to launch XIGDUO XR®
 ( Corporate News - 14-Dec-17   16:34 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top